“Considered by peers as ‘one of
the best generic Hatch-Waxman
litigation firms on the east coast.’”
– LMG Life Sciences
Visit our new blog at www.biosimilarsip.com
“Rothwell Figg is known for ‘meticulous patent drafting.’ Solely based in the capital, [Rothwell Figg] knows all the ins and outs of the D.C. scene and the USPTO.”
Post-Grant Trial Practice
“[This] compact yet heavy-hitting IP boutique has a client list that is the envy of many. Marquee names are drawn here for several compelling reasons: a persuasive win rate in high-stakes cases, the advanced technical backgrounds of its litigators, great comparative value and renowned expertise in post-grant procedures.”
Visit our new blog at www.ptablaw.com
Represented Mylan Pharmaceutical in an infringement claim made by Bristol-Myers Squibb related to the drug Buspar (buspirone).
Bristol-Myers motioned to dismiss antitrust counterclaims made by Mylan. The Court ruled a summary judgment of noninfringement. The court also denied Bristol’s motion and suing Mylan on it, as well as held that Bristol had acted in an objectively unreasonable fashion in listing the metabolite patent for buspirone in the Orange Book.
Bristol-Myers settled the antitrust claims by paying $535 million, including $35 million to Mylan after an initial ruling in favor of Mylan, 29 State Attorneys General, and several plaintiff class action groups who had joined Mylan’s suit.
company’s IP case
Patent troll CyberFone Systems LLC alleges Warner Bros. Entertainment Inc., CBS Interactive Inc., and dozens of other companies infringed a patent which covers a system of entering transaction data into databases because it covers an abstract concept rather than a specific invention.
The district court granted defendants motion for summary judgment that CyberFone’s patent was invalid under USC 101. Rothwell Figg took the lead in drafting and arguing the motion on behalf of the defendants. Rothwell Figg also took the lead in drafting and arguing against CyberFone’s appeal to the Federal Circuit.
February 2014, the three-judge Federal Circuit panel upheld the District of Delaware’s ruling that invalidated a software patent that CyberFone Systems LLC; alleged the 81 companies including CBS, CNN and Fox News infringed because it was not patent eligible under 35 USC 101.
Shaping a 360°
defense for leading
360° IP Performance
Rothwell Figg is a multifaceted intellectual property firm for high-stakes legal matters.
- Aydin Harston Quoted in Bloomberg Law Article on Federal Circuit Ruling Leaving Certain Pharma Patents Vulnerable
Partner Aydin H. Harston is quoted in a Bloomberg Law article on a Federal Circuit ruling that could leave some pharmaceutical patents susceptible to challenges based on inherent obviousness. In the case, Persion Pharmaceuticals LLC v. Alvogen…
- Leo Loughlin Leading Table Topic at 2020 INTA Annual Meeting
Partner Leo M. Loughlin will lead a table topic on "The Effects of B&B Hardware Five Years Later" on April 25, 2020, at the International Trademark Association's (INTA) Annual Meeting in Singapore. Table talks are a…
- Daniel Shores at MassBio Event on Protecting Trade Secrets and Maximizing Value
Partner Daniel L. Shores will participate in a panel organized by the Massachusetts Biotechnology Council (MassBio) titled "Are Your Trade Secrets Walking Out The Door?" on February 5, 2020, in Cambridge, Massachusetts. Mr. Shores and other experts will…
- Chabad Prevails in District Court Rulings, Sanctions Against Russia Top $120 Million
Rothwell Figg and its co-counsel, Lewin & Lewin, LLP, secured another victory on behalf of pro bono client Agudas Chasidei Chabad of United States in Chabad’s lawsuit against the Russian Federation. In a series of decisions and…
- Alternative Dispute Resolution
- Biologics and Biosimilars
- Biology and Biotechnology
- Electrical and Computer
- Food and Drug Administration Practice
- Hatch-Waxman Litigation
- International Trade Commission
- Licensing and Transactions
- Media and Financial Services
- Patent Prosecution
- Post-Grant Trial Practice
- Privacy, Data Protection, and Cybersecurity
- Software, E-Commerce and Business Methods
- Trade Secrets
- Trademark Trial and Appeal Board
- Unfair Competition
- Federal Circuit Affirms District Court Decision Dismissing Three Patents Asserted Against Client Fandango
- Rothwell Figg Achieves Rare Reversal of Section 101 Rejection
- District of Delaware Judge Dismisses Patent Infringement Cases With Prejudice Under 35 U.S.C. § 101, Resulting in Complete Victory for Clients Donuts, Inc. and Enom, LLC